Literature DB >> 26015402

p53-induced autophagy and senescence.

Xinbing Sui1,2, Weidong Han1,2, Hongming Pan1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26015402      PMCID: PMC4494899          DOI: 10.18632/oncotarget.4170

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


× No keyword cloud information.
p53, the “cellular gatekeeper” and the “guardian of the cellular genome”, is the most commonly mutated tumor suppressor in human cancer. In response to diverse stresses (that is, DNA damage, nutrient deprivation, oncogenic activation, hypoxia, oxidative stress, hyperproliferative signals and other forms of stress), p53 can be activated and subsequently functions as a transcription factor to orchestrate various biological outputs such as transient cell cycle arrest, apoptosis, cellular senescence, differentiation, metabolism, as well as regulation of autophagy [1]. Autophagy is a dynamic catabolic process by which cytoplasmic components are targeted to a double-membrane vesicle called autophagosomes and subsequently delivered to the lysosome for terminal degradation and recycling [2]. When the cells are subjected to stressful stimuli such as starvation, autophagy is rapidly upregulated to restore their metabolic homeostasis and sustain energy requirements, thus facilitating their survival under stressful conditions. However, excessive or persistent autophagy is also shown to promote cell death. A series of stress signals can induce autophagy, including p53, nutrient deprivation, hypoxia, endoplasmic reticulum stress and so on. The direct evidence from Scherz-Shouval et al. suggests that p53-dependent regulation of autophagy supports cell survival in the face of chronic starvation [3]. The central checkpoints that regulate autophagy are AMPresponsive protein kinase (AMPK) and mammalian target of rapamycin (mTOR) [2]. Cellular senescence is a stress response that accompanies with the irreversible arrest and senescent morphology. Senescence may be initiated by various insults and has an important role in limiting cell proliferation, however, the mechanisms controlling cellular senescence are still debated [4]. Increasing evidence indicate that p53 and AMPK/mTOR pathway are critical mediators of the senescence response [5, 6]. Thus, p53 can induce cell cycle arrest and then active mTOR converts this arrest into senescence (geroconversion). Seemingly paradoxically, p53 can also function as a suppressor of cellular senescence by blocking the mTOR pathway [6]. Both p53 and mTOR are also involved in regulation of autophagy. mTOR inhibits autophagy. However, it remains to be determined whether p53- induced autophagy is associated with suppression of senescence (gerosuppression). We have recently shown that p53 facilitated cell survival by inducing autophagy under the deprivation of serum [7]. Under serum starvation, an increased autophagic flux was observed in the HCT116 p53+/+ cells but not in the HCT116 p53−/− cells, suggesting that p53 promoted autophagy under serum-starved conditions. we showed p53-dependent autophagy protected cancer cells from starvation-induced death and inhibition of autophagy by the treatment with 3-MA resulted in a large number of cell death. Thus, p53-induced autophagy functions as a survival signal in response to serum starvation. To determine the impact of p53-induced autophagy on cellular senescence, we assessed cell cycle and staining with β-gal. We found that p53 induces cell cycle arrest and cell quiescence (not senescence) in response to serum starvation. However, β-gal activity was significantly enhanced in the serum-starved HCT116 p53−/− cells, as compared with the serum-starved HCT116 p53+/+ cells. These results indicate that p53 may act as a suppressor of cellular senescence in response to serum starvation since β-gal is a well-known marker presented in senescent cells. Next, we investigated whether inhibition of p53- dependent autophagy may promote cellular senescence. As mentioned above, increased autophagic flux and lack of the senescent phenotype were found in the serum-starved HCT116 p53+/+ cells. After the treatment with autophagic inhibitor 3-MA, the autophagy was attenuated and β-gal activity was markedly enhanced in the starved HCT116 p53+/+ cells, but hardly changed in the starved p53−/− cells. These data indicate that inhibition of p53-dependent autophagy promotes cellular senescence. In addition, it was demonstrated that suppression of senescence through p53-dependent autophagy may occur partly through the inhibition of the mTOR pathway. Our results demonstrate that, in the absence of serum, p53 may activate autophagic flux and subsequent autophagy functions as a survival signal to inhibit cellular senescence partly through suppression of the mTOR pathway. This study delineates a potential association between autophagy and senescence and explains why p53 may suppress cellular senescence in response to starvation. Future experiments will further illuminate the molecular mechanisms responsible for the inhibitory effects of p53-indeced autophagy on cellular senescence. A better understanding of the role of p53 in autophagy and cellular senescence will hopefully provide new strategy for cancer therapy.
  7 in total

1.  Paradoxical suppression of cellular senescence by p53.

Authors:  Zoya N Demidenko; Lioubov G Korotchkina; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  p53 suppresses stress-induced cellular senescence via regulation of autophagy under the deprivation of serum.

Authors:  Xinbing Sui; Yong Fang; Haizhou Lou; Kaifeng Wang; Yu Zheng; Fang Lou; Wei Jin; Yinghua Xu; Wei Chen; Hongming Pan; Xian Wang; Weidong Han
Journal:  Mol Med Rep       Date:  2014-11-04       Impact factor: 2.952

Review 3.  Eaten alive: a history of macroautophagy.

Authors:  Zhifen Yang; Daniel J Klionsky
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

4.  p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation.

Authors:  Ruth Scherz-Shouval; Hilla Weidberg; Chagay Gonen; Sylvia Wilder; Zvulun Elazar; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

5.  Unravelling mechanisms of p53-mediated tumour suppression.

Authors:  Kathryn T Bieging; Stephano Spano Mello; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

Review 6.  Interaction between the Cockayne syndrome B and p53 proteins: implications for aging.

Authors:  Mattia Frontini; Luca Proietti-De-Santis
Journal:  Aging (Albany NY)       Date:  2012-02       Impact factor: 5.682

Review 7.  Cellular senescence and its effector programs.

Authors:  Rafik Salama; Mahito Sadaie; Matthew Hoare; Masashi Narita
Journal:  Genes Dev       Date:  2014-01-15       Impact factor: 11.361

  7 in total
  12 in total

1.  p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis.

Authors:  Shwetha K Shetty; Nivedita Tiwari; Amarnath S Marudamuthu; Bijesh Puthusseri; Yashodhar P Bhandary; Jian Fu; Jeffrey Levin; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2017-03-06       Impact factor: 4.307

Review 2.  A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.

Authors:  Yuhao Wang; Benjamin Bonavida
Journal:  Crit Rev Oncog       Date:  2018

Review 3.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

4.  Agmatine Ameliorates High Glucose-Induced Neuronal Cell Senescence by Regulating the p21 and p53 Signaling.

Authors:  Juhyun Song; Byeori Lee; Somang Kang; Yumi Oh; Eosu Kim; Chul-Hoon Kim; Ho-Taek Song; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2016-02-19       Impact factor: 3.261

5.  p73 regulates basal and starvation-induced liver metabolism in vivo.

Authors:  Zhaoyue He; Massimiliano Agostini; He Liu; Gerry Melino; Hans-Uwe Simon
Journal:  Oncotarget       Date:  2015-10-20

6.  Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells.

Authors:  Yunjin Zang; Ying Shi; Kai Liu; Luxin Qiao; Xianghua Guo; Dexi Chen
Journal:  Oncotarget       Date:  2017-02-21

Review 7.  p53 and metabolism: from mechanism to therapeutics.

Authors:  Fernando M Simabuco; Mirian G Morale; Isadora C B Pavan; Ana P Morelli; Fernando R Silva; Rodrigo E Tamura
Journal:  Oncotarget       Date:  2018-05-04

8.  Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling.

Authors:  Rabia Johnson; Samukelisiwe Shabalala; Johan Louw; Abidemi Paul Kappo; Christo John Frederick Muller
Journal:  Molecules       Date:  2017-09-22       Impact factor: 4.411

9.  Comparative Analysis of Whole-Transcriptome RNA Expression in MDCK Cells Infected With the H3N2 and H5N1 Canine Influenza Viruses.

Authors:  Pan Tao; Zhangyong Ning; Xiangqi Hao; Xi Lin; Qingxu Zheng; Shoujun Li
Journal:  Front Cell Infect Microbiol       Date:  2019-03-26       Impact factor: 5.293

10.  Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.

Authors:  Linda S Steelman; Steve L Abrams; Peter Ruvolo; Vivian Ruvolo; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Luca M Neri; Saverio Candido; Massimo Libra; James A McCubrey
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.